We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBDD
4551
DELISTED
iShares iBonds Mar 2023 Term Corporate ETF
IBDD
$962K ﹤0.01%
36,369
-3,402
-9% -$90.4K
HWKN icon
4552
Hawkins
HWKN
$2.74B
$960K ﹤0.01%
54,536
-5,110
-9% -$97.9K
QCRH icon
4553
QCR Holdings
QCRH
$1.74B
$960K ﹤0.01%
22,414
+2,929
+15% +$134K
SIX
4554
CALL
DELISTED
Six Flags Entertainment Corp.
SIX
$959K ﹤0.01%
14,400
-30,100
-68% -$1.93M
TCMD icon
4555
Tactile Systems Technology
TCMD
$548M
$958K ﹤0.01%
33,053
+15,101
+84% +$438K
TGTX icon
4556
PUT
TG Therapeutics
TGTX
$7.46B
$958K ﹤0.01%
116,800
+59,500
+104% +$520K
GNC
4557
CALL
DELISTED
GNC Holdings, Inc.
GNC
$955K ﹤0.01%
258,700
+85,500
+49% +$537K
CACI icon
4558
CALL
CACI
CACI
$14.8B
$953K ﹤0.01%
7,200
+4,300
+148% +$580K
RPT
4559
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$951K ﹤0.01%
64,553
-75,318
-54% -$1.04M
IQV icon
4560
PUT
IQVIA
IQV
$39B
$950K ﹤0.01%
9,700
+2,000
+26% +$204K
VRSK icon
4561
CALL
Verisk Analytics
VRSK
$23.6B
$950K ﹤0.01%
9,900
+4,300
+77% +$389K
PDCO
4562
CALL
DELISTED
Patterson Companies, Inc.
PDCO
$950K ﹤0.01%
26,300
+400
+2% +$14.6K
LDOS icon
4563
PUT
Leidos
LDOS
$18B
$949K ﹤0.01%
14,700
+1,500
+11% +$94K
RY icon
4564
Royal Bank of Canada
RY
$301B
$949K ﹤0.01%
11,621
+8,610
+286% +$683K
TVRD
4565
Tvardi Therapeutics
TVRD
$25.3M
$949K ﹤0.01%
2,155
FXF icon
4566
Invesco CurrencyShares Swiss Franc Trust
FXF
$395M
$947K ﹤0.01%
9,776
-2,078
-18% -$199K
UGA icon
4567
PUT
United States Gasoline Fund
UGA
$138M
$946K ﹤0.01%
29,700
-8,200
-22% -$251K
BERY
4568
CALL
DELISTED
Berry Global Group, Inc.
BERY
$945K ﹤0.01%
17,533
+545
+3% +$29.7K
SPWR
4569
DELISTED
SunPower Corporation Common Stock
SPWR
$945K ﹤0.01%
171,120
-443,392
-72% -$2.3M
SHLD
4570
PUT
DELISTED
Sears Holding Corporation
SHLD
$945K ﹤0.01%
263,900
-122,600
-32% -$606K
ARA
4571
DELISTED
American Renal Associates Holdings, Inc
ARA
$944K ﹤0.01%
54,254
+40,917
+307% +$565K
NORW
4572
DELISTED
Global X MSCI Norway ETF
NORW
$943K ﹤0.01%
71,762
-60,346
-46% -$807K
DOC icon
4573
CALL
Healthpeak Properties
DOC
$14.3B
$941K ﹤0.01%
36,100
+18,800
+109% +$498K
TM icon
4574
CALL
Toyota
TM
$226B
$941K ﹤0.01%
7,400
-2,200
-23% -$274K
CCMP
4575
CALL
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$941K ﹤0.01%
10,000
-2,400
-19% -$221K

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.